A McGill Distinguished Lecture in Human Genetics

The Lady Davis Institute and the McGill University-Génome Québec Innovation Centre
present
A McGill Distinguished Lecture in Human Genetics

Using genetics, epigenetics, and editing to reactivate fetal hemoglobin for therapy

Stuart H. Orkin, MD
Stuart H Orkin is Chair of Pediatric Oncology at the Dana Farber Cancer Institute and an HHMI Investigator.
His achievements include dissection of the molecular basis of the thalassemia, positional cloning of the first human disease gene, cloning of the first master regulator of blood cell development, and identification of a major silencer of fetal hemoglobin expression. A member of the National Academy of Sciences, his many awards include the Jessie Stevenson Kovalenko Medal of the National Academy for “important contributions to the medical sciences”.

For more info, click here.